Auspex Pharmaceuticals, Inc. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/118c5628-bc92-45da-b475-3b174a73ddd8/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-50.3M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001735 |
| FY 2013 | $-67.5M | 2001-03-01 – 2014-03-31 | evidence 0001564590-14-002127 |
| FY 2012 | $-13.4M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001735 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).